Citation

  • Authors: Tintignac, L. A., Sirri, V., Leibovitch, M. P., Lecluse, Y., Castedo, M., Metivier, D., Kroemer, G., Leibovitch, S. A.
  • Year: 2004
  • Journal: Mol Cell Biol 24 1809-21
  • Applications: in vitro / DNA / jetPEI
  • Cell types:
    1. Name: 10T1/2
    2. Name: HCT 116
      Description: Human colon carcinoma cells
      Known as: HCT116
    3. Name: HEK-293
      Description: Human embryonic kidney Fibroblast
      Known as: HEK293, 293

Abstract

The transcription factors MyoD and Myf-5 control myoblast identity and differentiation. MyoD and Myf-5 manifest opposite cell cycle-specific expression patterns. Here, we provide evidence that MyoD plays a pivotal role at the G(2)/M transition by controlling the expression of p21(Waf1/Cip1) (p21), which is believed to regulate cyclin B-Cdc2 kinase activity in G(2). In growing myoblasts, MyoD reaccumulates during G(2) concomitantly with p21 before entry into mitosis; MyoD is phosphorylated on Ser5 and Ser200 by cyclin B-Cdc2, resulting in a decrease of its stability and down-regulation of both MyoD and p21. Inducible expression of a nonphosphorylable MyoD A5/A200 enhances the MyoD interaction with the coactivator P/CAF, thereby stimulating the transcriptional activation of a luciferase reporter gene placed under the control of the p21 promoter. MyoD A5/A200 causes sustained p21 expression, which inhibits cyclin B-Cdc2 kinase activity in G(2) and delays M-phase entry. This G(2) arrest is not observed in p21(-/-) cells. These results show that in cycling cells MyoD functions as a transcriptional activator of p21 and that MyoD phosphorylation is required for G(2)/M transition.

Go to